
Equipment and Processing Report
- Equipment and Processing Report-05-21-2014
- Volume 0
- Issue 0
Advanced Aseptic Technology Provides Glass-Free Delivery of Injectable Drugs
Catalent's Advasept platform uses blow-fill-seal technology to aseptically manufacture, fill, and seal a polymeric primary container for injectable drugs.
Catalent Pharma Solutions launched its Advasept technology for the advanced aseptic filling of injectable drugs. The new platform provides a glass-free, aseptically filled, primary container that reduces or eliminates many concerns associated with traditional glass vials, including the potential for glass particulate contamination and the risk of accidental breakage in transit or use. Catalent uses blow-fill-seal manufacturing technology to aseptically manufacture, fill, and seal a polymeric primary container. Advasept stoppered vials are currently produced in 10-mL, 50-mL and 100-mL sizes and are available with pop-off or twist-off tops. Containers can be tailored to meet the unique needs of customers across many markets, such as biologics, pharmaceuticals, generics, and animal health.
Source:
Articles in this issue
over 11 years ago
Evaluating Facility cGMP Compliance By Reviewing Gowning Practicesover 11 years ago
Continuous Solid-Dosage Manufacturing Moves Forwardover 11 years ago
Packaging Innovations Displayed at INTERPHEX 2014over 11 years ago
System Improves Vial Drying and HandlingNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





